NCT06174480

Brief Summary

Many information is available regarding human adaptations to cold or hypoxia. Adaptations to these environments and physical exercise constitute responses to physiological stress aimed at amplifying the organism's reactions and improving its performance. However, studies conducted so far to understand these adaptations and their underlying mechanisms have been organized in a dissociated manner, with each study focusing on only one of these specific situations (cold, hypoxia, or exercise). Understanding cross-adaptations is crucial, as human beings are often simultaneously exposed to several of these stimuli, and understanding this cross-exposure can be considered a prerequisite for pre-acclimatization strategies to these different environments. Cross-adaptations has been defined as follows: "It simply involves considering that long-term exposure (either continuous or intermittent) to a given unfavorable environment not only increases tolerance to that particular environment but also leads to gains or losses of tolerance to other unfavorable factors that the adapted organism had never encountered before." When specifically examining cross-adaptations to cold and hypoxia, only one study focusing on the human model is available. The lack of perspectives and positions regarding the results calls for further investigations. The main objective of this study is to assess the effect of repeated exposures to cryostimulation on the variation of the respiratory exchange ratio in hypoxia during exercise.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 18, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

January 25, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2025

Completed
Last Updated

January 26, 2024

Status Verified

December 1, 2023

Enrollment Period

1.1 years

First QC Date

December 8, 2023

Last Update Submit

January 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • variation of the respiratory quotient during exercise

    respiratory exchange ratio will be measured continuously using a portable metabolic station to analyze gas exchanges

    Comparing the average values obtained during exercise in hypoxia at baseline and after 15 days.

Study Arms (2)

Control Group

NO INTERVENTION

Participants will not undergo cryostimulation exposure but will only receive 2 1-hour hypoxia sessions at FiO2 13.5% for 1 hour, at 2-week interval

Cryostimulation Group

EXPERIMENTAL

Participants will be exposed to cryostimulation (-50°C, forced ventilation for 3 minutes) during 20 sessions over 2 weeks and will undergo 2 hypoxia sessions at FiO2 13.5% for 1 hour, at 2-week interval

Other: Cryostimulation

Interventions

Cryostimulation (-50°C, forced ventilation for 3 minutes) during 20 sessions over 2 weeks.

Cryostimulation Group

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Having a high level of physical activity according to the criteria of the World Health Organization, assessed using the Global Physical Activity Questionnaire (GPAQ);
  • No exposure to cryostimulation or hypoxia (FiO2 13.5%, equivalent to an altitude of 3500 m) in the last 90 days;
  • No planned sports competition during the 4 weeks of the protocol;
  • Maintaining a stable physical activity level (regular training, without interruption or specific competition, including sports training programs) anticipated for 4 weeks;
  • No history of respiratory conditions (asthma, respiratory allergies, exercise-induced asthma, exertional dyspnea);
  • Absence of any chronic medical condition;
  • No ongoing medication treatments;
  • Covered by a French Social Security;
  • Informed consent, signed by the subject after clear and fair information about the study.

You may not qualify if:

  • Subject under treatment;
  • Simultaneous participation in another clinical research study;
  • Individuals with enhanced protection, namely minors, individuals deprived of liberty by judicial or administrative decision, persons staying in a healthcare or social facility, adults under legal protection, and finally, patients in emergency situations;
  • Subject presenting a contraindication to hypoxia and/or cryostimulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Laboratoire MOVE UR 20296 - Poitiers University

Poitiers, 86000, France

Location

Clinical Investigation Centre INSERM CIC1402 - Poitiers University - CHU POITIERS

Poitiers, 86021, France

Location

MeSH Terms

Conditions

HypoxiaMotor Activity

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2023

First Posted

December 18, 2023

Study Start

January 25, 2024

Primary Completion

February 25, 2025

Study Completion

May 25, 2025

Last Updated

January 26, 2024

Record last verified: 2023-12

Locations